Last reviewed · How we verify
Nitric oxide by inhalation INOMAX
Nitric oxide by inhalation INOMAX is a Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 2 development. Also known as: INOMAX.
At a glance
| Generic name | Nitric oxide by inhalation INOMAX |
|---|---|
| Also known as | INOMAX |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Exposure of Taxi Drivers to Ultrafine Particles and Black Carbon Within Their Vehicles (NA)
- Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction. (PHASE3)
- Pulmonary Hypertension in Left Heart Disease
- iNO300 Therapy in Critically Ill Patients With Pneumonia (EARLY_PHASE1)
- Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma (PHASE4)
- Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing
- Determining Airway pH by Compartmental Exhaled Nitric Oxide Levels During Alkaline Buffer Challenge (PHASE2)
- Diagnostic and Translational Values of Point-of-care Blood Eosinophils and Exhaled Nitric Oxide (FeNO) in People Referred by Primary Care for Suspected Asthma
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nitric oxide by inhalation INOMAX CI brief — competitive landscape report
- Nitric oxide by inhalation INOMAX updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI
Frequently asked questions about Nitric oxide by inhalation INOMAX
What is Nitric oxide by inhalation INOMAX?
Nitric oxide by inhalation INOMAX is a Small molecule drug developed by Assistance Publique - Hôpitaux de Paris.
Who makes Nitric oxide by inhalation INOMAX?
Nitric oxide by inhalation INOMAX is developed by Assistance Publique - Hôpitaux de Paris (see full Assistance Publique - Hôpitaux de Paris pipeline at /company/assistance-publique-h-pitaux-de-paris).
Is Nitric oxide by inhalation INOMAX also known as anything else?
Nitric oxide by inhalation INOMAX is also known as INOMAX.
What development phase is Nitric oxide by inhalation INOMAX in?
Nitric oxide by inhalation INOMAX is in Phase 2.
Related
- Manufacturer: Assistance Publique - Hôpitaux de Paris — full pipeline
- Also known as: INOMAX
- Compare: Nitric oxide by inhalation INOMAX vs similar drugs
- Pricing: Nitric oxide by inhalation INOMAX cost, discount & access